Literature DB >> 3096863

Pharmacologic hypogonadotropism--an advantage for hMG-induced follicular-maturation and succeeding fertilization.

G Bettendorf, W Braendle, C Sprotte, W Poels, W Lichtenberg, C Lindner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3096863     DOI： 10.1055/s-2007-1012399

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  4 in total

1.  The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program.

Authors:  V Remorgida; P Anserini; S Croce; M Costa; A Ferraiolo; A Centonze; G Gaggero; G L Capitanio
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

2.  In vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) program at the University of Hamburg, Federal Republic of Germany: experiences with two different stimulation protocols.

Authors:  G Bettendorf; W Braendle; L Bispink; V Lichtenberg; C Lindner; C Schirren
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-10

3.  Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels.

Authors:  R G Brzyski; G S Jones; S Oehninger; A A Acosta; C H Kruithoff; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

4.  Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease.

Authors:  J Smitz; P Devroey; M Camus; J Deschacht; L Van Waesberghe; A Wisanto; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.